Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan.…
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan.…
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan.…
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 17:05 ET | Source: Annexon Biosciences BRISBANE, Calif., Jan.…
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:…
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 16, 2026 16:30 ET | Source: Cellyan Biotechnology Co., Ltd HONG…
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
January 02, 2026 16:05 ET | Source: Terns Pharmaceuticals, Inc. FOSTER CITY,…
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
January 02, 2026 17:00 ET | Source: Intelligent Bio Solutions, Inc. NEW…
reAlpha (Nasdaq: AIRE) Announces National Loan Officer Recruitment Program with RSU Incentives
DUBLIN, Ohio, Dec. 30, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq:…
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU)…
